Concepedia

Laszlo Radvanyi

LR

Statistics

Publications

86

Citations

11K

H-Index

50

Active since

1948

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Ontario Institute for Cancer Research

University of Toronto

Melanoma Institute Australia

Moffitt Cancer Center

Laszlo Radvanyi is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, oncology, and life sciences.

Publications per year

1948–2024

86

Publications

86

Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

Weiyi Peng, Jie Qing Chen, Chengwen Liu et al. · Cancer Discovery · 2015 · 1.5K citations · Full text

Medicine, Immunology, Oncology +17

PD-L1 expression and prognostic impact in glioblastoma

Edjah K. Nduom, Jun Wei, Nasser K. Yaghi et al. · Neuro-Oncology · 2015 · 614 citations

Medicine, Immunology, Oncology +17

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

Jason R. Westin, Fuliang Chu, Min Zhang et al. · The Lancet Oncology · 2013 · 530 citations

Pharmacy, Immunology, Pharmacotherapy +13

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

Yan Lan, Dong Zhang, Chunxiao Xu et al. · Science Translational Medicine · 2018 · 488 citations

Life Sciences, Immunology, Oncology +17

PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines

Weiyi Peng, Chengwen Liu, Chunyu Xu et al. · Cancer Research · 2012 · 434 citations

Life Sciences, Immunology, Oncology +11

1–5 of 86